NCI-H295R, a Human Adrenal Cortex-Derived Cell Line, Expresses Purinergic Receptors Linked to Ca2+-Mobilization/Influx and Cortisol Secretion

被引:18
作者
Nishi, Haruhisa [1 ]
Arai, Hirokazu [1 ]
Momiyama, Toshihiko [1 ]
机构
[1] Jikei Univ, Sch Med, Tokyo, Japan
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
ADRENOCORTICAL-FASCICULATA CELLS; GLOMERULOSA CELLS; CALCIUM-CHANNELS; ALDOSTERONE PRODUCTION; ADENYLATE-CYCLASE; MESSENGER-RNA; STEROIDOGENESIS; ATP; PURINOCEPTORS; PATHWAYS;
D O I
10.1371/journal.pone.0071022
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purinergic receptor expression and involvement in steroidogenesis were examined in NCI-H295R (H295R), a human adrenal cortex cell line which expresses all the key enzymes necessary for steroidogenesis. mRNA/protein for multiple P1 (A(2A) and A(2B)), P2X (P2X(5) and P2X(7)), and P2Y (P2Y(1), P2Y(2), P2Y(6), P2Y(12), P2Y(13), and P2Y(14)) purinergic receptors were detected in H295R. 2MeS-ATP (10-1000 mu M), a P2Y(1) agonist, induced glucocorticoid (GC) secretion in a dose-dependent manner, while other extracellular purine/pyrimidine agonists (1-1000 mu M) had no distinct effect on GC secretion. Extracellular purines, even non-steroidogenic ones, induced Ca2+-mobilization in the cells, independently of the extracellular Ca2+ concentration. Increases in intracellular Ca2+ concentration induced by extracellular purine agonists were transient, except when induced by ATP or 2MeS-ATP. Angiotensin II (AngII: 100 nM) and dibutyryl-cyclic AMP (db-cAMP: 500 mu M) induced both GC secretion and Ca2+-mobilization in the presence of extracellular Ca2+ (1.2 mM). GC secretion by AngII was reduced by nifedipine (10-100 mu M); whereas the Ca2+ channel blocker did not inhibit GC secretion by 2MeS-ATP. Thapsigargin followed by extracellular Ca2+ exposure induced Ca2+-influx in H295R, and the cells expressed mRNA/protein of the component molecules for store-operated calcium entry (SOCE): transient receptor C (TRPC) channels, calcium release-activated calcium channel protein 1 (Orai-1), and the stromal interaction molecule 1 (STIM1). In P2Y(1)-knockdown, 2MeS-ATP-induced GC secretion was significantly inhibited. These results suggest that H295R expresses a functional P2Y(1) purinergic receptor for intracellular Ca2+-mobilization, and that P2Y(1) is linked to SOCE-activation, leading to Ca2+-influx which might be necessary for glucocorticoid secretion.
引用
收藏
页数:13
相关论文
共 47 条
  • [1] Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R
    Akizuki, Osamu
    Inayoshi, Atsushi
    Kitayama, Tetsuya
    Yao, Kozo
    Shirakura, Shiro
    Sasaki, Katsutoshi
    Kusaka, Hideaki
    Matsubara, Masahiro
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (2-3) : 424 - 434
  • [2] Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis
    Aritomi, Shizuka
    Wagatsuma, Hirotaka
    Numata, Tomohiro
    Uriu, Yoshitsugu
    Nogi, Yasuko
    Mitsui, Akira
    Konda, Tomoyuki
    Mori, Yasuo
    Yoshimura, Michihiro
    [J]. HYPERTENSION RESEARCH, 2011, 34 (02) : 193 - 201
  • [3] Belloni AS, 2007, INT J MOL MED, V20, P859
  • [4] HORMONAL-REGULATION OF ANGIOTENSIN-II TYPE-1 RECEPTOR EXPRESSION AND AT(1)-R MESSENGER-RNA LEVELS IN HUMAN ADRENOCORTICAL-CELLS
    BIRD, IM
    MASON, JI
    RAINEY, WE
    [J]. ENDOCRINE RESEARCH, 1995, 21 (1-2) : 169 - 182
  • [5] CA2+-REGULATED EXPRESSION OF STEROID HYDROXYLASES IN H295R HUMAN ADRENOCORTICAL-CELLS
    BIRD, IM
    MATHIS, JM
    MASON, JI
    RAINEY, WE
    [J]. ENDOCRINOLOGY, 1995, 136 (12) : 5677 - 5684
  • [6] Pharmacological and biophysical properties of the human P2X5 receptor
    Bo, XN
    Jiang, LH
    Wilson, HL
    Kim, M
    Burnstock, G
    Surprenant, A
    North, RA
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (06) : 1407 - 1416
  • [7] Purine and pyrimidine receptors
    Burnstock, G.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (12) : 1471 - 1483
  • [8] Pathophysiology and therapeutic potential of purinergic signaling
    Burnstock, G
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (01) : 58 - 86
  • [9] Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death
    Burnstock, G.
    Verkhratsky, A.
    [J]. CELL DEATH & DISEASE, 2010, 1 : e9 - e9
  • [10] Physiology and pathophysiology of purinergic neurotransmission
    Burnstock, Geoffrey
    [J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (02) : 659 - 797